← Back to Search

MOV'D + Fitbit Monitoring for Sedentary Lifestyle

N/A

Waitlist Available

Led By Marily A. Oppezzo, PhD MSRD

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Spend more than 55% of time sedentary at work

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 5 days at baseline, 5 days post 1-month follow-up

Awards & highlights

Study Summary

This trial tests the effects of MOV'D, a remotely-delivered intervention consisting of videos on increasing physical activity and behavior change techniques, on reducing prolonged sitting at work and increasing moderate to vigorous physical activity.

Who is the study for?

This trial is for full-time employees who spend over half their work time sitting, can safely exercise (as determined by the PAR-Q), read English, and have a smartphone with internet. It's not suitable for those who don't meet these criteria.Check my eligibility

What is being tested?

The MOV'D program aims to reduce long sitting periods at work using 'exercise snacks'—short bursts of activity—and behavior change techniques shared via social media support groups. Participants will also self-monitor with Fitbit devices.See study design

What are the potential side effects?

Since this intervention involves moderate physical activity, potential side effects may include typical exercise-related discomforts such as muscle soreness or fatigue. However, participants are screened to ensure it's safe for them to exercise.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I spend most of my workday sitting down.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 5 days at baseline, 5 days post 1-month follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~5 days at baseline, 5 days post 1-month follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 days at baseline, 5 days post 1-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in average active workday hours at post-intervention

Change in average workday MVPA minutes at post-intervention

Secondary outcome measures

Change in average active workday hours at follow-up

Change in average workday MVPA minutes at follow-up

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: MOV'D plus Fitbit Self-MonitoringExperimental Treatment2 Interventions

Treatment participants will be sent a Fitbit and study-provided account, and assigned to a private, study-created Twitter support group of 10 participants. Within the private group of 10, each participant is also further paired with a peer to be that person's peer coach, setting weekly exercise snack goals and practicing behavior change techniques.

Group II: Fitbit-Only Self-MonitoringActive Control1 Intervention

Control participants will be sent a Fitbit and study-provided account and will self-monitor physical activity for the duration of the study period (2 months).

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,396 Previous Clinical Trials

17,341,483 Total Patients Enrolled

3 Trials studying Sedentary Lifestyle

635 Patients Enrolled for Sedentary Lifestyle

National Heart, Lung, and Blood Institute (NHLBI)NIH

3,843 Previous Clinical Trials

47,817,036 Total Patients Enrolled

5 Trials studying Sedentary Lifestyle

2,473 Patients Enrolled for Sedentary Lifestyle

National Institutes of Health (NIH)NIH

2,705 Previous Clinical Trials

7,507,214 Total Patients Enrolled

1 Trials studying Sedentary Lifestyle

78 Patients Enrolled for Sedentary Lifestyle

Media Library

MOV'D (Move Often eVery Day) Clinical Trial Eligibility Overview. Trial Name: NCT05360485 — N/A

Sedentary Lifestyle Research Study Groups: Fitbit-Only Self-Monitoring, MOV'D plus Fitbit Self-Monitoring

Sedentary Lifestyle Clinical Trial 2023: MOV'D (Move Often eVery Day) Highlights & Side Effects. Trial Name: NCT05360485 — N/A

MOV'D (Move Often eVery Day) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05360485 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there presently opportunities for enrolment in this experiment?

"Clinicaltrials.gov indicates that this medical study is actively seeking participants, beginning on May 1st 2022 with the recent update being posted 3 days later."

Answered by AI

How many people are participating in the program at maximum capacity?

"Affirmative. The information hosted on clinicaltrials.gov confirms that this trial is still recruiting participants, with the post date being May 1st 2022 and the last edit coming at May 3rd of same year. There are 50 patients needed to be enrolled from a single medical facility."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Peer Motivation Coaches, Social Media-based Support Group, and Behavior Change Strategies to Decrease Prolonged Sitting and Increase Moderate Exercise Snacks

Marily Ann Oppezzo 2022. "Peer Motivation Coaches, Social Media-based Support Group, and Behavior Change Strategies to Decrease Prolonged Sitting and Increase Moderate Exercise Snacks". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05360485.